A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
Clinical trial NCT05084508 · COMPLETED
Trial details
- NCT number
- NCT05084508
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-03
- Primary completion
- 2024-02-09
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.